Acura Pharmaceuticals, Inc. Secures Bridge Funding
August 16, 2006 16:04 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Aug. 16, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $450,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Announces 2nd Quarter 2006 Financial Results and OxyADF Tablet Development Status
July 27, 2006 16:05 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., July 27, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $2.6 million or $0.01 per share for the quarter ending June 30, 2006 compared to a...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
June 30, 2006 17:23 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., June 30, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $335,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
May 24, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., May 24, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $800,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Announces Appointment of Richard Markham as Director
May 15, 2006 16:00 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., May 15, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) is pleased to announce the appointment of Richard J. Markham to its Board of Directors.
Mr. Markham brings to...
Acura Pharmaceuticals, Inc. Announces First Quarter 2006 Results
April 26, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., April 26, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $4.2 million or $0.01 per share for the quarter ending March 31, 2006, compared to...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
March 27, 2006 17:32 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., March 27, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $750,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports 2005 Financial Results, and Updates OxyADF Tablet Development, Commercial Strategy and Cash Reserves
February 21, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Feb. 21, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $7.1 million or $0.04 per share for the quarter ending December 31, 2005 compared to...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
January 31, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Jan. 31, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $750,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports Financial Results for Q3-05, Bridge Funding, Conversion of Preferred Shares, Update on OxyADF Development and Cash Reserves
November 10, 2005 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Nov. 10, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $1.6 million or $0.07 per share for the quarter ended September 30, 2005 compared...